Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record history now includes a new revision labeled v3.6.3, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-05T13:39:52.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the study's record history and the older revision (v3.6.0) was removed from the list. This reflects an update to the page's version history rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-28T08:23:03.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    New June 2026 entries were added to the Record History, including items such as 'Check who can join', 'Find Contact Information', and 'Study Status', along with a page revision note 'Revision: v3.6.0'.
    Difference
    2%
    Check dated 2026-06-14T03:27:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.5) has been added to the record history, and the previous revision entry (v3.5.4) has been removed from the list.
    Difference
    0.1%
    Check dated 2026-06-06T23:36:21.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.4, was added to the study's record history, indicating an updated version of the record and replacing the previous v3.5.3 in the history timeline.
    Difference
    0.1%
    Check dated 2026-05-16T10:12:57.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A site interface revision marker was updated from version v3.5.2 to v3.5.3, reflecting a non-content update to the page’s release/build labeling.
    Difference
    0.1%
    Check dated 2026-04-24T22:20:42.000Z thumbnail image

Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.